Literature DB >> 11375139

Treatment of Alzheimer's disease with cholinesterase inhibitors.

L S Schneider1.   

Abstract

The cholinergic system is the most severely affected neurotransmitter system in patients with Alzheimer's disease, and therapeutic strategies have been developed to restore cholinergic function in these patients. This article reviews the present status of cholinesterase inhibitors for the treatment of Alzheimer's disease. It then discusses treatment approaches and current and future issues regarding efficacy and safety.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11375139     DOI： 10.1016/s0749-0690(05)70072-0

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


  19 in total

1.  Anticholinesterase activity of endemic plant extracts from Soqotra.

Authors:  Hussein Bakthira; Nasser A Awadh Ali; Norbert Arnold; Axel Teichert; Ludger Wessjohann
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-04-02

Review 2.  New pathways in drug discovery for Alzheimer's disease.

Authors:  Eric R Siemers; Robert A Dean; Ronald Demattos; Patrick C May
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

3.  Protective Effects of Inosine on Memory Consolidation in a Rat Model of Scopolamine-Induced Cognitive Impairment: Involvement of Cholinergic Signaling, Redox Status, and Ion Pump Activities.

Authors:  Fernanda Cardoso Teixeira; Bruna da Silveira de Mattos; Julia Eisenhardt de Mello; Juliane Cardoso; Luiza Spohr; Karina Pereira Luduvico; Mayara Sandrielly Pereira Soares; Fabiano Barbosa Carvalho; Jessie Martins Gutierres; Anelize de Oliveira Campello Felix; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Neurochem Res       Date:  2021-10-08       Impact factor: 3.996

4.  Inhibitory effect of some tropical green leafy vegetables on key enzymes linked to Alzheimer's disease and some pro-oxidant induced lipid peroxidation in rats' brain.

Authors:  Ganiyu Oboh; Ayodele Jacobson Akinyemi; Adedayo Oluwaseun Ademiluyi; Fatai Olumide Bello
Journal:  J Food Sci Technol       Date:  2011-11-04       Impact factor: 2.701

5.  Cholinergic influence on memory stages: A study on scopolamine amnesic mice.

Authors:  Rahul Agrawal; Ethika Tyagi; Gunjan Saxena; Chandishwar Nath
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

6.  Flavoring extracts of Hemidesmus indicus roots and Vanilla planifolia pods exhibit in vitro acetylcholinesterase inhibitory activities.

Authors:  Anish Kundu; Adinpunya Mitra
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

Review 7.  Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.

Authors:  Abraham Fisher
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

8.  Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease.

Authors:  Leslie J Gonzalez Rothi; Renee Fuller; Susan A Leon; Diane Kendall; Anna Moore; Samuel S Wu; Bruce Crosson; Kenneth M Heilman; Stephen E Nadeau
Journal:  J Int Neuropsychol Soc       Date:  2009-03       Impact factor: 2.892

9.  A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine.

Authors:  Seyed Behzad Jazayeri; Arash Amanlou; Naghmeh Ghanadian; Parvin Pasalar; Massoud Amanlou
Journal:  Daru       Date:  2014-01-08       Impact factor: 3.117

10.  Anticholinesterase and Antioxidative Properties of Aqueous Extract of Cola acuminata Seed In Vitro.

Authors:  Ganiyu Oboh; Ayodele J Akinyemi; Olasunkanmi S Omojokun; Idowu S Oyeleye
Journal:  Int J Alzheimers Dis       Date:  2014-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.